Stay updated on UC-961 in Relapsed CLL Clinical Trial
Sign up to get notified when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.

Latest updates to the UC-961 in Relapsed CLL Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision history updated: v3.5.0 removed and v3.5.2 added.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded B-cell chronic lymphocytic leukemia as a condition term and included Genetic and Rare Diseases Information Center as a resources entry.SummaryDifference0.2%

- Check38 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This update does not modify study data or page content.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.4.2 was added; the old government funding/status notice was removed, and the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedDifference0.4%

Stay in the know with updates to UC-961 in Relapsed CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.